Related Experiment Video
Updated: Jul 9, 2026
08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
Glioblastoma multiforme: evidence-based approach to therapy
1University of Chicago, Department of Neurology, MC 2030, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. mnichola@neurology.bsd.uchicago.edu
Expert Review of Anticancer Therapy
|January 10, 2008
Summary
Glioblastoma multiforme (GBM) treatment varies globally. This review details the standard US care for newly diagnosed GBM, including surgery, radiotherapy, and chemotherapy, based on supporting evidence.
Area of Science:
- Neuro-oncology
- Cancer therapy
- Clinical research
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor.
- Standard GBM treatment in Western countries involves surgery, radiotherapy, and chemotherapy.
- Treatment accessibility and cost significantly impact therapeutic options globally.
Purpose of the Study:
- To review the current standard of care for newly diagnosed Glioblastoma multiforme in the USA.
- To examine the evidence supporting the established treatment protocols for GBM.
- To highlight the components of multimodal therapy for GBM.
Main Methods:
- Literature review of clinical trials and guidelines.
- Analysis of evidence supporting standard GBM treatment modalities.
- Focus on treatment protocols for newly diagnosed patients.
Main Results:
- The standard of care in the USA for newly diagnosed GBM includes surgery, radiotherapy, and chemotherapy.
- Evidence supports the efficacy of this multimodal approach.
- Variations in treatment exist globally due to cost and accessibility.
Conclusions:
- The current US standard of care for GBM is evidence-based multimodal therapy.
- Understanding the evidence is crucial for optimizing GBM patient outcomes.
- Global disparities in GBM treatment necessitate further research and policy considerations.
